| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| SELLAS Life Sciences Group, Inc. | Director | Common Stock | 10.4K | $65K | $6.25 | Jan 22, 2024 | Direct |
| SELLAS Life Sciences Group, Inc. | Director | Stock Option (Right to Buy) | 10K | Jan 22, 2024 | Direct | ||
| Acorda Therapeutics, Inc. | Director | Non-Employee Stock Option | 1.2K | Jun 22, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| SLS | SELLAS Life Sciences Group, Inc. | Jan 22, 2024 | 2 | $0 | 4 | Jan 25, 2024 | Director |
| ACOR | Acorda Therapeutics, Inc. | Jun 22, 2023 | 1 | $0 | 4 | Jun 23, 2023 | Director |
| SLS | SELLAS Life Sciences Group, Inc. | Feb 2, 2023 | 2 | $0 | 4 | Feb 3, 2023 | Director |
| ACOR | ACORDA THERAPEUTICS INC | Jan 1, 2023 | 1 | $0 | 4 | Jan 4, 2023 | Director |
| SLS | SELLAS Life Sciences Group, Inc. | Jan 31, 2022 | 2 | $0 | 4 | Feb 1, 2022 | Director |
| ACOR | ACORDA THERAPEUTICS INC | Jan 1, 2022 | 0 | $0 | 3 | Jan 5, 2022 | Director |
| ACOR | ACORDA THERAPEUTICS INC | Jan 1, 2022 | 1 | $0 | 4 | Jan 4, 2022 | Director |